DK578887A - Antihypertensiva - Google Patents

Antihypertensiva

Info

Publication number
DK578887A
DK578887A DK578887A DK578887A DK578887A DK 578887 A DK578887 A DK 578887A DK 578887 A DK578887 A DK 578887A DK 578887 A DK578887 A DK 578887A DK 578887 A DK578887 A DK 578887A
Authority
DK
Denmark
Prior art keywords
antihypertensives
certain
relates
enhancement
conjunctive
Prior art date
Application number
DK578887A
Other languages
English (en)
Other versions
DK167209B1 (da
DK578887D0 (da
Inventor
Richard C Dage
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK578887D0 publication Critical patent/DK578887D0/da
Publication of DK578887A publication Critical patent/DK578887A/da
Application granted granted Critical
Publication of DK167209B1 publication Critical patent/DK167209B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK578887A 1986-11-05 1987-11-04 Synergistisk aktivt praeparat til behandling af hypertension DK167209B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92778586A 1986-11-05 1986-11-05
US92778586 1986-11-05

Publications (3)

Publication Number Publication Date
DK578887D0 DK578887D0 (da) 1987-11-04
DK578887A true DK578887A (da) 1988-05-06
DK167209B1 DK167209B1 (da) 1993-09-20

Family

ID=25455252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK578887A DK167209B1 (da) 1986-11-05 1987-11-04 Synergistisk aktivt praeparat til behandling af hypertension

Country Status (11)

Country Link
EP (1) EP0268146B1 (da)
JP (1) JP2612175B2 (da)
KR (1) KR950013758B1 (da)
AT (1) ATE59781T1 (da)
DE (1) DE3767287D1 (da)
DK (1) DK167209B1 (da)
ES (1) ES2036560T3 (da)
GR (1) GR3001375T3 (da)
IE (1) IE59905B1 (da)
PH (1) PH23818A (da)
ZA (1) ZA878182B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE333279T1 (de) * 1997-05-19 2006-08-15 Zonagen Inc Kombinationstherapie zur modulation der humanen sexualreaktion
AU759825B2 (en) * 1997-12-16 2003-05-01 Pfizer Products Inc. Combination effective for the treatment of impotence
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
US20130274245A1 (en) * 2012-04-11 2013-10-17 Jan BLUMENSTEIN Composition For Prevention of Vasoactivity in the Treatment of Blood Loss and Anemia
EP3865120A1 (en) 2013-07-19 2021-08-18 Boehringer Ingelheim Vetmedica GmbH Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
CN110721164B (zh) 2013-12-04 2024-09-17 勃林格殷格翰动物保健有限公司 匹莫苯的改善的药物组合物
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130647A (en) * 1977-07-08 1978-12-19 Pfizer Inc. Methods for treating congestive heart failure and ischemic heart disease
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation

Also Published As

Publication number Publication date
KR950013758B1 (ko) 1995-11-15
JP2612175B2 (ja) 1997-05-21
KR880005934A (ko) 1988-07-21
ZA878182B (en) 1988-05-02
JPS63132837A (ja) 1988-06-04
DE3767287D1 (de) 1991-02-14
PH23818A (en) 1989-11-23
DK167209B1 (da) 1993-09-20
IE59905B1 (en) 1994-04-20
EP0268146B1 (en) 1991-01-09
GR3001375T3 (en) 1992-09-11
ES2036560T3 (es) 1993-06-01
DK578887D0 (da) 1987-11-04
EP0268146A1 (en) 1988-05-25
IE872975L (en) 1988-05-05
ATE59781T1 (de) 1991-01-15

Similar Documents

Publication Publication Date Title
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
MA27113A1 (fr) Activateurs de glucokinase oxygenes cycloalkyle ou substitues cycloalkyle
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK578887D0 (da) Antihypertensiva
ATE39357T1 (de) Derivate von griseolicsaeure und ihre verwendung.
DK462687A (da) Forbindelse til behandling af retrovirusinfektioner.
IT1207498B (it) Procedimento per la preparazione di composizioni plasto-elastomeriche poliolefiniche, mediante vulcanizzazione dinamica.
ES2058343T3 (es) Piridinas disubstituidas.
FI864597A (fi) Kardiotoniska tiazoloner.
ES2020953B3 (es) Complejos de tetrahidro-3,4-furanodiamina-n-n'platino.
ATE79615T1 (de) Cardiotonische phenyloxazolone.
DE3784768D1 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
EP0116628A4 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE.
ES2024503B3 (es) Mejoras en, o relacionadas con, el reforzamiento del terreno.
IT8621410A0 (it) Composizione per il miglioramento del candeggio.
SE7909787L (sv) Sett att framstella en antihemofilifaktor
SE7909788L (sv) Sett att framstella en antihemofilifaktor
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
ATE69609T1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
DE3776488D1 (da)
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
DE3785272D1 (de) Derivate von 2,2-dimethylcyclopropancarbonsaeure.
ATE77952T1 (de) Verwendung von 1,4-dihydropyridinderivaten.
ATE86863T1 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
DE69615221D1 (de) Fluoriertes propranolol und ahnliche verfahren

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired